Text
Radiotherapy of Ocular Diseases: 1st International Symposium on Special Aspects of Radiotherapy, Berlin, May 1996
Here’s a deeper summary of the material and its significance:
Interdisciplinary Perspective: contributions come from ophthalmologists, oncologists, radiation physicists, etc. The goal is to improve outcomes by combining expertise.
Karger
Balancing Effects & Toxicity: much of the content deals with not just efficacy (tumor control / improvement) but also the safety aspects: acute & late side effects of radiotherapy on ocular tissues (lens, retina, optic nerve, etc).
Karger
+1
Techniques & Technology: exploring the use of proton beams, photon beams, plaque therapies, and improving how the dose is delivered and controlled. Modern imaging (CT, MRI) helps in planning.
Karger
Disease‑Specific Discussions:
Uveal melanomas: ways to treat while preserving eye/vision.
Retinoblastoma and lymphomas: specialized consideration of pediatric treatments etc.
Non‑tumorous conditions: e.g. orbital disease like endocrine orbitopathy, or vascular lesions, or macular degeneration.
No other version available